These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 19570126)

  • 1. The role of methadone in cancer pain treatment--a review.
    Leppert W
    Int J Clin Pract; 2009 Jul; 63(7):1095-109. PubMed ID: 19570126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone use in cancer patients with pain: a review.
    Bruera E; Sweeney C
    J Palliat Med; 2002 Feb; 5(1):127-38. PubMed ID: 11839235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of methadone in the management of pain in cancer patients.
    Bruera E; Neumann CM
    Oncology (Williston Park); 1999 Sep; 13(9):1275-82; discussion 1285-8, 1291. PubMed ID: 10509323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
    Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
    J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences.
    Ripamonti C; De Conno F; Groff L; Belzile M; Pereira J; Hanson J; Bruera E
    Ann Oncol; 1998 Jan; 9(1):79-83. PubMed ID: 9541687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone as a First-Line Opioid in Cancer Pain Management: A Systematic Review.
    Mercadante S; Bruera E
    J Pain Symptom Manage; 2018 Mar; 55(3):998-1003. PubMed ID: 29101087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
    Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
    Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid and adjuvant analgesics: compared and contrasted.
    Khan MI; Walsh D; Brito-Dellan N
    Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of methadone.
    Lugo RA; Satterfield KL; Kern SE
    J Pain Palliat Care Pharmacother; 2005; 19(4):13-24. PubMed ID: 16431829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration.
    Davis MP; Walsh D
    Support Care Cancer; 2001 Mar; 9(2):73-83. PubMed ID: 11305074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone: an effective alternative to morphine for pain relief in cancer patients.
    Shelton BW; Deynes-Romero J; Tofani-Montalvo M; Ramírez-Rivera J; Jaumne-Anselmi F
    Bol Asoc Med P R; 2008; 100(3):7-10. PubMed ID: 19227708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone treatment for pain states.
    Toombs JD; Kral LA
    Am Fam Physician; 2005 Apr; 71(7):1353-8. PubMed ID: 15832538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses.
    Svendsen K; Borchgrevink P; Fredheim O; Hamunen K; Mellbye A; Dale O
    Palliat Med; 2011 Oct; 25(7):725-32. PubMed ID: 21378066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine to methadone conversion: an interpretation of published data.
    Pollock AB; Tegeler ML; Morgan V; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Mar; 28(2):135-40. PubMed ID: 20555039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.